Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.75

-2.4%

3:56 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (13243)	9/30/2004 3:28:52 PM
From: NeuroInvestment	Read Replies (2) of 52153

<<Clear causation>> While I have tried to forget the whole ugly affair, my recollection is that no abnormalities were found in patients that had not combined either fenfluramine or dexfenfluramine with phentermine. Yet phentermine was given a pass, and Wyeth took all the body blows. My point is only that--you don't even have to be John Edwards to see this as a potential gold mine, causality be damned. Harry NeuroInvestment

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next